Nuix (NXL) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
23 Dec, 2025Executive summary
Annualised Contract Value (ACV) grew 8.3% year-over-year to AUD 216.2 million, with 97% from subscription licences and strong customer tenure over 5 years.
Statutory revenue increased 6.9% to AUD 105.2 million, driven by Asia Pacific and North America, with recurring subscription revenue at 94%.
Cash EBITDA rose 30.6% to AUD 13.4 million, while statutory EBITDA declined 10.8% to AUD 15.3 million due to legal and restructuring costs.
Nuix Neo platform rollout accelerated, with ACV for Neo up 361% to AUD 18.9 million and customer count doubling to 46.
Underlying cash flow remained positive at AUD 7 million, but overall free cash flow was negative due to legal and restructuring payments.
Financial highlights
Net dollar retention at 109.6%, down from 110.1% prior year, due to higher churn and longer procurement cycles.
Churn rose to 5.4%, mainly from North America and a large EMEA customer project completion.
R&D spend increased 7.3% year-over-year, with a higher expense component and 27% of revenue.
Multi-year deals comprised 22% of revenue, down from 24% prior year; subscription revenue remains high at 94%.
Gross margin stable at 89.8%; cash EBITDA margin at 12.7%.
Outlook and guidance
Full-year ACV growth expected in the 11%-16% range (constant currency), reflecting variability in procurement cycles.
Revenue growth targeted to exceed operating cost growth; underlying cash flow to remain positive for the full year.
Continued rollout of Nuix Neo and focus on higher value, enterprise contracts.
Ongoing investment in R&D, especially in Nuix Neo and AI capabilities, expected to drive future growth.
Technology enhancements and restructuring aimed at improving efficiency and customer value in the second half of FY25.
Latest events from Nuix
- ACV and revenue rose sharply, led by Neo, with strong cash flow and Linkurious acquisition pending.NXL
H1 202623 Feb 2026 - Double-digit growth in ACV, revenue, and EBITDA, with new platform driving momentum.NXL
H2 202423 Jan 2026 - Robust FY24 results and AI-driven innovation set the stage for further growth.NXL
AGM 202414 Jan 2026 - ACV up 8% to AUD 228.4m, Nuix Neo ACV up 132%, and cash EBITDA up 24.5% year-over-year.NXL
H2 202523 Nov 2025 - AI-driven innovation and rapid processing power set new standards for data solutions.NXL
Investor Day 2025 Presentation22 Sep 2025